Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Net Loans (2016 - 2018)

Fortress Biotech has reported Change in Net Loans over the past 3 years, most recently at $176000.0 for Q3 2018.

  • Quarterly results put Change in Net Loans at $176000.0 for Q3 2018, up 486.67% from a year ago — trailing twelve months through Sep 2018 was $988000.0 (up 513.66% YoY), and the annual figure for FY2017 was $597000.0, up 610.71%.
  • Change in Net Loans for Q3 2018 was $176000.0 at Fortress Biotech, down from $214000.0 in the prior quarter.
  • Over the last five years, Change in Net Loans for FBIO hit a ceiling of $520000.0 in Q4 2017 and a floor of $17000.0 in Q1 2017.
  • Median Change in Net Loans over the past 3 years was $81000.0 (2016), compared with a mean of $143625.0.
  • Peak annual rise in Change in Net Loans hit 613.33% in 2018, while the deepest fall reached 358.82% in 2018.
  • Fortress Biotech's Change in Net Loans stood at $84000.0 in 2016, then surged by 519.05% to $520000.0 in 2017, then tumbled by 66.15% to $176000.0 in 2018.
  • The last three reported values for Change in Net Loans were $176000.0 (Q3 2018), $214000.0 (Q2 2018), and $78000.0 (Q1 2018) per Business Quant data.